Related Experiment Video
Updated: Jul 14, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
Published on: May 4, 2015
Influence of platelet size on outcome after myocardial infarction
J F Martin1, P M Bath, M L Burr
1Department of Medicine, King's College School of Medicine and Dentistry, London, UK.
Insights
Larger mean platelet volume (MPV), a measure of platelet size, is linked to increased risk of death and recurrent heart attacks after a heart attack. Platelet count showed no such association, suggesting MPV is an independent risk factor.
Area of Science:
- Cardiology
- Hematology
Background:
- Platelet characteristics influence ischemic heart disease.
- The association between platelet size/count and outcomes post-myocardial infarction (MI) is not fully understood.
Purpose of the Study:
- To investigate the relationship between mean platelet volume (MPV) and platelet count with death and reinfarction following an index MI.
Main Methods:
- MPV and platelet count were measured in 1716 men six months after MI.
- Outcomes (death, recurrent ischemic events) were assessed over two years.
Main Results:
- Higher MPV was significantly associated with increased risk of fatal or non-fatal ischemic events (p < 0.001).
- Men who died had significantly larger MPV than survivors (p < 0.001).
- No significant difference in platelet count was observed between groups.
Conclusions:
- MPV is an independent risk factor for recurrent myocardial infarction.
- MPV, not platelet count, predicts adverse outcomes after MI.
Abstract:
Although platelet characteristics have an important influence on ischaemic heart disease, the nature of the association of platelet size and platelet count with death and reinfarction after an index heart attack is unknown. Mean platelet volume (MPV), a determinant of platelet reactivity, was measured in 1716 men six months after myocardial infarction (MI). Deaths and recurrent ischaemic heart disease events were then assessed at two years. MPV was greater in 126 men who had a further ischaemic event (fatal or non-fatal) than in the 1590 men who had no further MI (p less than 0.001). In addition, the MPV was larger in men who died than in those who did not (p less than 0.001). There was no difference in platelet count between these groups. When analysed by quartiles, consistent trends of increasing age-adjusted relative odds of death and recurrent ischaemic events were noted for MPV. MPV did not correlate with known ischaemic heart disease risk factors such as blood pressure, blood lipids, fibrinogen, white cell count, or plasma viscosity. We believe that MPV is a further independent risk factor for recurrent MI.
Related Concept Videos
Anatomy of the Heart
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Mitral Stenosis I: Introduction
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology

